Nathalie C Stoer
Overview
Explore the profile of Nathalie C Stoer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bjorge T, Stoer N, Hverven S, Nygard M, Trope A, Engesaeter B
Int J Cancer
. 2025 Feb;
PMID: 39921417
As many countries are transitioning from cytology to human papillomavirus (HPV) testing as the primary cervical cancer screening test, we evaluated the impact of cumulative HPV screening during the implementation...
2.
Lofling L, Stoer N, Sloan E, Nafisi S, Fortner R, Botteri E
Int J Cancer
. 2025 Jan;
PMID: 39865612
Cancer diagnosis and therapy cause stress to the body. Preclinical studies have shown that stress hormones can stimulate tumor progression and metastasis by interacting with β-adrenergic receptors, and that β-blockers...
3.
4.
Ellingjord-Dale M, Nygaard A, Stoer N, Bo R, Landro N, Brunvoll S, et al.
Int J Infect Dis
. 2024 Oct;
149:107263.
PMID: 39419167
Objectives: There is a lack of large studies on long-COVID symptoms with symptoms measurements before the onset of COVID-19. Therefore, long-COVID is still poorly defined. Methods: The Norwegian COVID-19 Cohort...
5.
Stoer N, Vangen S, Singh D, Fortner R, Hofvind S, Ursin G, et al.
Br J Cancer
. 2024 May;
131(1):126-137.
PMID: 38740969
Background: It is important to monitor the association between menopausal hormone therapy (HT) use and breast cancer (BC) risk with contemporary estimates, and specifically focus on HT types and new...
6.
Nafisi S, Stoer N, Veierod M, Randel K, Hoff G, Lofling L, et al.
Am J Gastroenterol
. 2024 Feb;
119(7):1402-1411.
PMID: 38300127
Introduction: To examine the association between low-dose aspirin use and risk of colorectal cancer (CRC). Methods: In this nationwide cohort study, we identified individuals aged 50 years or older residing...
7.
Lofling L, Stoer N, Andreassen B, Ursin G, Botteri E
Breast Cancer Res
. 2023 Aug;
25(1):101.
PMID: 37649039
Background: Previous studies assessed the prognostic effect of aspirin, statins, and metformin in breast cancer (BC) patients, with inconclusive results. Methods: We performed a nationwide population-based cohort study to evaluate...
8.
Sanjinez C, Botteri E, Stoer N, Lofling L
Lung Cancer
. 2023 Apr;
179:107187.
PMID: 37060880
Objectives: Epidemiological studies have reported an association between antimuscarinics and reduced risk of cancer, including lung cancer (LC). However, the potential association between antimuscarinic use and LC prognosis has not...
9.
Lofling L, Stoer N, Nafisi S, Ursin G, Hofvind S, Botteri E
Eur J Epidemiol
. 2023 Mar;
38(4):413-426.
PMID: 36877278
Several studies evaluated the association between aspirin use and risk of breast cancer (BC), with inconsistent results. We identified women aged ≥ 50 years residing in Norway between 2004 and...
10.
Dong L, Nygard M, Stoer N, Klungsoyr O, Hansen B
Int J Cancer
. 2023 Mar;
153(2):399-406.
PMID: 36866965
Human papillomavirus (HPV) vaccine effectiveness may differ between settings. Here we present the first real-world effectiveness study of HPV vaccination on high-grade cervical lesions from Norway, among women who received...